These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2020-005647-24 A PHASE II, OPEN LABEL, RANDOMISED TRIAL OF IPILIMUMAB AND NIVOLUMAB WITH CONCURRENT INTRACRANIAL STEREOTACTIC RADIOTHERAPY VERSUS IPILIMUMAB AND NIVOLUMAB ALONE IN PATIENTS WITH MELANOMA BRAIN METAST... not-yet-due